UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort)

Key facts

Sponsor

Emory University

Principal Investigator

Chia-shi Wang, MD, MS, MD

Emory University

Intervention

Standard of Care(behavioral)

Enrollment

58 target

Eligibility

18 years · All sexes

Timeline

2019 – 2025

Study locations (3)

• Children's Healthcare of Altanta, Atlanta, Georgia, United States
• University of Minnesota Children's Hospital, Minneapolis, Minnesota, United States
• Oregon Health and Science University, Portland, Oregon, United States

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Idiopathic nephrotic syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT06820866
  Non-invasive Diagnosis of Idiopathic Nephrotic Syndromes
  Assistance Publique - Hôpitaux de Paris
• ACTIVE NOT RECRUITINGPHASE3NCT05627557
  A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome
  Hoffmann-La Roche
• RECRUITINGNCT04207580
  A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.
  University Hospital, Limoges

See all trials for Idiopathic nephrotic syndrome →